Literature DB >> 32296513

Evaluation of the stability of vancomycin solutions at concentrations used in clinical services.

Morgane Masse1, Stéphanie Genay1, Anthony Martin Mena1, Natacha Carta1, Damien Lannoy1, Christine Barthélémy1, Bertrand Décaudin1, Pascal Odou1.   

Abstract

Entities:  

Keywords:  chromatography, high pressure liquid; drug stability-indicating method; infusion, intravenous; particulate contamination; vancomycin hydrochloride

Mesh：

Substances：

Year:  2020        PMID： 32296513      PMCID： PMC7147549          DOI： 10.1136/ejhpharm-2019-002076

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN： 2047-9956


× No keyword cloud information.
  19 in total

1.  Particulate matter contamination of intravenous antibiotics aggravates loss of functional capillary density in postischemic striated muscle.

Authors:  Hans-Anton Lehr; Joachim Brunner; Ramzan Rangoonwala; C James Kirkpatrick
Journal:  Am J Respir Crit Care Med       Date:  2002-02-15       Impact factor: 21.405

Review 2.  Antibiotics for gram-positive bacterial infections: vancomycin, quinupristin-dalfopristin, linezolid, and daptomycin.

Authors:  Tammy S Lundstrom; Jack D Sobel
Journal:  Infect Dis Clin North Am       Date:  2004-09       Impact factor: 5.982

3.  Vancomycin-Associated Cast Nephropathy.

Authors:  Yosu Luque; Kevin Louis; Chantal Jouanneau; Sandrine Placier; Emmanuel Esteve; Dominique Bazin; Eric Rondeau; Emmanuel Letavernier; Alice Wolfromm; Clément Gosset; Anna Boueilh; Maren Burbach; Perrine Frère; Marie-Christine Verpont; Sophie Vandermeersch; Dominique Langui; Michel Daudon; Vincent Frochot; Laurent Mesnard
Journal:  J Am Soc Nephrol       Date:  2017-01-12       Impact factor: 10.121

4.  Harmonization of strategies for the validation of quantitative analytical procedures. A SFSTP proposal--part III.

Authors:  Ph Hubert; J-J Nguyen-Huu; B Boulanger; E Chapuzet; N Cohen; P-A Compagnon; W Dewé; M Feinberg; M Laurentie; N Mercier; G Muzard; L Valat; E Rozet
Journal:  J Pharm Biomed Anal       Date:  2007-07-17       Impact factor: 3.935

5.  Development and validation of an HPLC method for vancomycin and its application to a pharmacokinetic study.

Authors:  María José de Jesús Valle; Francisco González López; Amparo Sánchez Navarro
Journal:  J Pharm Biomed Anal       Date:  2008-06-14       Impact factor: 3.935

6.  Vancomycin syringe study shows significant reduction in dosing variability after introducing a revised protocol.

Authors:  Aurélie Foinard; Bertrand Décaudin; Nicolas Simon; Christine Barthélémy; Laurent Storme; Pascal Odou
Journal:  Acta Paediatr       Date:  2013-12-03       Impact factor: 2.299

7.  Influence of vancomycin infusion methods on endothelial cell toxicity.

Authors:  Maryline Drouet; Feng Chai; Christine Barthélémy; Gilles Lebuffe; Bertrand Debaene; Bertrand Décaudin; Pascal Odou
Journal:  Antimicrob Agents Chemother       Date:  2014-11-24       Impact factor: 5.191

8.  High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus.

Authors:  Rafael San-Juan; Mario Fernández-Ruiz; Oriol Gasch; Mariana Camoez; Francisco López-Medrano; María Ángeles Domínguez; Benito Almirante; Belén Padilla; Miquel Pujol; José María Aguado
Journal:  J Antimicrob Chemother       Date:  2017-07-01       Impact factor: 5.790

9.  2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).

Authors:  Gilbert Habib; Patrizio Lancellotti; Manuel J Antunes; Maria Grazia Bongiorni; Jean-Paul Casalta; Francesco Del Zotti; Raluca Dulgheru; Gebrine El Khoury; Paola Anna Erba; Bernard Iung; Jose M Miro; Barbara J Mulder; Edyta Plonska-Gosciniak; Susanna Price; Jolien Roos-Hesselink; Ulrika Snygg-Martin; Franck Thuny; Pilar Tornos Mas; Isidre Vilacosta; Jose Luis Zamorano
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

10.  The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.

Authors:  A Charmillon; E Novy; N Agrinier; M Leone; A Kimmoun; B Levy; B Demoré; J Dellamonica; C Pulcini
Journal:  Clin Microbiol Infect       Date:  2016-05-01       Impact factor: 8.067
View more
  4 in total

Review 1.  Strategies to prevent drug incompatibility during simultaneous multi-drug infusion in intensive care units: a literature review.

Authors:  Laura Négrier; Anthony Martin Mena; Gilles Lebuffe; Pascal Odou; Stéphanie Genay; Bertrand Décaudin
Journal:  Eur J Clin Pharmacol       Date:  2021-03-25       Impact factor: 2.953

2.  Competence Mining of Vancomycin (VAN) in the Management of Infections Due to Bacterial Strains With High VAN Minimum Inhibitory Concentrations (MICs): A Novel Dosing Strategy Based on Pharmacokinetic/Pharmacodynamic Modeling.

Authors:  Xiangqing Song; Meizi Zeng; Yi Wu; Yong Pan
Journal:  Front Microbiol       Date:  2021-04-22       Impact factor: 5.640

3.  Stability of vancomycin hydrochloride employed in antimicrobial seal solutions of central intravenous catheters.

Authors:  Daniele Porto Barros; Priscilla Sete de Carvalho Onofre; Fernando Luiz Affonso Fonseca; Paulo César Pires Rosa; Mavilde da Luz Gonçalves Pedreira; Maria Angélica Sorgini Peterlini
Journal:  Rev Lat Am Enfermagem       Date:  2022

4.  Optimising an Infusion Protocol Containing Cefepime to Limit Particulate Load to Newborns in a Neonatal Intensive Care Unit.

Authors:  Anthony Martin Mena; Morgane Masse; Laura Négrier; Thu Huong Nguyen; Bruno Ladam; Laurent Storme; Christine Barthélémy; Pascal Odou; Stéphanie Genay; Bertrand Décaudin
Journal:  Pharmaceutics       Date:  2021-03-08       Impact factor: 6.321
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.